Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical (LFCR) Long-Term Debt Repayments: 2010-2025

Historic Long-Term Debt Repayments for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to $145.1 million.

  • Lifecore Biomedical's Long-Term Debt Repayments fell 0.80% to $145.1 million in Q2 2025 from the same period last year, while for May 2025 it was $145.8 million, marking a year-over-year decrease of 45.45%. This contributed to the annual value of $145.8 million for FY2025, which is 0.64% down from last year.
  • As of Q2 2025, Lifecore Biomedical's Long-Term Debt Repayments stood at $145.1 million, which was up 46,244.73% from $313,000 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Long-Term Debt Repayments registered a high of $146.2 million during Q2 2024, and its lowest value of -$29.5 million during Q4 2024.
  • In the last 3 years, Lifecore Biomedical's Long-Term Debt Repayments had a median value of $3.1 million in 2023 and averaged $46.2 million.
  • As far as peak fluctuations go, Lifecore Biomedical's Long-Term Debt Repayments soared by 344,160.00% in 2023, and later crashed by 15,397.41% in 2024.
  • Lifecore Biomedical's Long-Term Debt Repayments (Quarterly) stood at $38,000 in 2021, then climbed by 28.95% to $49,000 in 2022, then surged by 293.88% to $193,000 in 2023, then tumbled by 15,397.41% to -$29.5 million in 2024, then dropped by 0.80% to $145.1 million in 2025.
  • Its Long-Term Debt Repayments was $145.1 million in Q2 2025, compared to $313,000 in Q1 2025 and -$29.5 million in Q4 2024.